Drinking coffee, smoking may protect against cholangitis

July 8, 2014
Drinking coffee, smoking may protect against cholangitis

(HealthDay)—Coffee consumption and smoking might protect against the development of primary sclerosing cholangitis (PSC), according to a study published in the June issue of Clinical Gastroenterology and Hepatology.

Ina Marie Andersen, from the Oslo University Hospital in Norway, and colleagues distributed a questionnaire to 240 patients with PSC as well as 245 randomly chosen individuals from the Norwegian Bone Marrow Donor Registry ().

The researchers found that a lower proportion of patients with PSC were daily coffee drinkers than control subjects, both currently (76 versus 86 percent; odds ratio [OR], 0.52; P = 0.006) and at the age of 18 years (35 versus 49 percent; OR, 0.58; P = 0.003). Differences among men mainly accounted for these associations. In patients, 20 percent were ever (current or former) daily smokers, compared with 43 percent of control subjects (OR, 0.33; P < 0.001). There was an association between ever daily smoking before PSC diagnosis and older age at diagnosis (42 versus 32 years; P < 0.001). Among females, fewer patients ever used hormonal contraception versus controls (51 versus 85 percent; P < 0.001). There was a strong correlation in women between increasing number of children before the diagnosis of PSC and increasing age at diagnosis (P < 0.001).

"Coffee consumption and smoking might protect against development of PSC," the authors write.

Explore further: Coffee and cigarettes may protect against liver disease, study says

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Coffee and cigarettes may protect against liver disease, study says

December 16, 2013
Coffee and cigarette smoking may protect against the rare liver disease Primary Sclerosing Cholangitis (PSC), study shows.

Consuming coffee linked to lower risk of detrimental liver disease, study finds

May 19, 2013
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Low vitamin B12 linked to postural orthostatic tachycardia

December 23, 2013
(HealthDay)—During adolescence, low vitamin B12 levels are associated with postural orthostatic tachycardia syndrome (POTS), according to a study published online Dec. 23 in Pediatrics.

Dermatologist care tied to better self-detection of melanoma

April 25, 2014
(HealthDay)—Patients with self-detected primary melanoma who have an established dermatologist are more likely to have thinner lesions at the time of diagnosis, according to research published in the May issue of the Journal ...

Six percent of colorectal cancer found to be interval tumors

April 16, 2014
(HealthDay)—Six percent of patients with colorectal cancer (CRC) have interval cancers, which develop within six to 60 months of colonoscopy, according to a study published in the April issue of Gastroenterology.

Smoking cessation reduces risk of cataract extraction

January 7, 2014
(HealthDay)—Smoking cessation correlates with a reduction in the risk of cataract extraction, although the risk persists for more than 20 years, according to a study published online Jan. 2 in JAMA Ophthalmology.

Recommended for you

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

winthrom
not rated yet Jul 08, 2014
For the uninformed, the disease "primary sclerosing cholangitis (PSC)" is defined:

http://www.mayocl...20029446

I see a correlation without explanation yet.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.